Published Date: August, 2017
A recent report published by Infinium Global Research on cardiovascular implants market provides in depth analysis of segments and sub-segments in global as well as regional cardiovascular implants market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional cardiovascular implants market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cardiovascular implants market. According to report the global cardiovascular implants market is projected to grow at a CAGR of 6.1% over the forecast period of 2017-2023.
Cardiovascular Disease (CVD) is generally refers to conditions affecting the heart or blood vessels. It’s usually associated with a build-up of fatty deposits inside the arteries – known as atherosclerosis, narrowing or blockage of blood vessels and an increased risk of blood clots. It can also be associated with damage to arteries in organs such as the brain, heart, kidneys and eyes. CVD is one of the main causes of death and disability in the UK, but it can often largely be prevented with a healthy lifestyle. These cardiovascular diseases generally triggered by various factors such as life style, heart rhythm complications, smoking, high cholesterol, lack of exercise, diabetes, obesity, poor diet, alcohol consumption and high blood pressure. Among these factors, high blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%.
CVDS includes coronary artery diseases (CAD) such as angina and myocardial infarction (heart attack). Other CVDS are peripheral arterial disease, stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis. there various treatment options available in the market to treat these cardiovascular diseases such as drug therapy (ace inhibitors, antiarrhythmic, aspirin therapy, beta-blocker therapy, clot buster drugs, diuretics, etc.), changing lifestyle habits, and medical surgeries (stents, coronary stents, peripheral stents, heart bypass surgery, pacemakers, implantable cardioverter defibrillators, and heart transplants). These implants are lifesaving medium to improve the patient’s disease condition and are made of various materials, which include metals, alloys, biomaterials, and polymers.
Some of the key driving factors attributing to the growth of this include increasing number of patients with cardiovascular diseases such as hypertension, heart failures and coronary artery diseases, and shortage of number of heart donors. In addition, changing lifestyle, alcohol consumption, growing obesity and smoking further are propelling the market growth, as these factors increase the bold glucose and lipid levels, which results in serious cardiovascular diseases. However, there are certain restraining factors which could hamper the growth of the market, which includes high-risk nature and high complication rates associated with considerable mortality, due to frequent use of implants in older populations with frequent co-morbidities. Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to increasing prevalence of CVD diseases, growing awareness among the population, improving healthcare infrastructure, rise in healthcare spending, and favorable government policies.
Figure 1: Global Cardiovascular Implants Market by Value 2015-2023
The report on global cardiovascular implants market covers segments such as, type. On the basis of type the global cardiovascular implants market is categorized into coronary stents, peripheral stents, heart valves, implanted cardiac pacemakers, implantable cardioverter defibrillator and cardiac resynchronization therapy (CRT) device.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023.
Figure 2: Global Cardiovascular Implants Market by Region, CAGR % 2017-2023
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.
The report provides profiles of the companies in the global cardiovascular implants market such as, Abbott Laboratories, B-Braun, Boston Scientific, Medtronic plc., St. Jude Medical, Inc., C. R. Bard, Inc., Cook Medical, Terumo Corporation, Edwards Lifesciences and AMG International.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global cardiovascular implants market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cardiovascular implants market. Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future trends in the cardiovascular implants market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the cardiovascular implants market to understand the present and future trends in this market and formulate their strategies accordingly.
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Cardiovascular Implants Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Cardiovascular Implants Market
4. Global Cardiovascular Implants Market by Type
4.1. Coronary Stents
4.2. Peripheral Stents
4.3. Heart Valves
4.4. Implanted Cardiac Pacemakers
4.5. Implantable Cardioverter Defibrillator
4.6. Cardiac Resynchronization Therapy (CRT) Device
5. Global Cardiovascular Implants Market by Region 2017-2023
5.1. North America
5.1.1. North America Cardiovascular Implants Market by Type
5.1.2. North America Cardiovascular Implants Market by Country
5.2.1. Europe Cardiovascular Implants Market by Type
5.2.2. Europe Cardiovascular Implants Market by Country
5.3.1. Asia-Pacific Cardiovascular Implants Market by Type
5.3.2. Asia-Pacific Cardiovascular Implants Market by Country
5.4.1. RoW Cardiovascular Implants Market by Type
5.4.2. RoW Cardiovascular Implants Market by Sub-region
6. Company Covered
6.1. Abbott Laboratories
6.3. Boston Scientific
6.4. Medtronic Plc.
6.5. St. Jude Medical, Inc.
6.6. C. R. Bard, Inc.
6.7. Cook Medical
6.8. Terumo Corporation
6.9. Edwards Lifesciences
6.10. AMG International
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter